{
    "2019-10-22": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Top Stock Reports for U.S. Bancorp, Bristol-Myers Squibb & Morgan Stanley",
                "features": {
                    "keywords": [
                        "U.S. Bancorp",
                        "Bristol-Myers Squibb",
                        "Morgan Stanley"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Goldman Sachs Is Either Mad or Brilliant on Junk Bonds",
                "features": {
                    "keywords": [
                        "Goldman Sachs",
                        "Junk Bonds"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}